Actively Recruiting
Description of Patient Adherence to Heart Failure Remote Monitoring and Its Determinants
Led by Centre Hospitalier Régional Metz-Thionville · Updated on 2024-12-09
150
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying patients with heart failure who have received telemonitoring after hospitalization at the Centre Hospitalier Régional Metz-Thionville. The study aims to describe patient adherence to remote monitoring and understand factors that influence whether patients continue or stop using telemonitoring. This observational study collects both past data and conducts interviews to explore patient experiences and reasons for interruption. Patients included have received heart failure telemonitoring since 2020. Those still in follow-up will be monitored for up to 12 months or until their follow-up ends. Patients who interrupted their follow-up less than a month before or during the study will be contacted by phone and invited to participate in a semi-structured interview after giving oral consent. This approach helps investigators learn why patients stop telemonitoring. Participants' socio-demographic and clinical data are collected from medical records, and telemonitoring data are extracted from software records. Telephone interviews explore reasons for follow-up interruptions. The main outcome measured is the time until a break in remote monitoring, with secondary outcomes including proportions of patients stopping follow-up at 6, 12, and 24 months. Monitoring can continue up to four years after telemonitoring starts.
CONDITIONS
Brief Title
Description of Patient Adherence to Heart Failure Remote Monitoring and Its Determinants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years or older
- Diagnosed with heart failure
- Received telemonitoring for heart failure from Centre Hospitalier Régional Metz-Thionville
- Clearly informed about the research study
- Provided oral consent for telephone interview
You will not qualify if you...
- Refusal to allow reuse of data for the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to four years
Participants who undergo routine care are observed through remote monitoring of their heart failure condition.
Trial Site Locations
Total: 2 locations
1
CHR Metz Thionville Hopital de Mercy
Metz, France, 57085
Actively Recruiting
2
CHR Metz-Thionville Hopital Bel Air
Thionville, France, 57100
Actively Recruiting
Research Team
A
Arpiné EL NAR, PhD
C
Céline PETITJEAN
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here